Mohammad Sheibani

56 papers receiving 689 citations

Mohammad Sheibani's Hit Papers

Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches 2022 · 152 citations
1520+1+2Years since publication50100150

Peers

Mohammad Sheibani
Comparison fields: 5 of 100
  • Biological Psychiatry 33
  • Endocrine and Autonomic Systems 51
  • Cardiology and Cardiovascular Medicine 172
  • Biophysics 25
  • Pharmacology 32
Replace Perle Totoson with:
Perle Totoson France
Di Ye China
Mingjing Yan China
María Dolores Mauricio Spain
Francesc Jiménez‐Altayó Spain
Paul A. Volden United States
Patricia Marchio Spain
Hyeongseok Kim South Korea
Maryam Shayan Iran
Nastaran Rahimi Iran
Mohammad Sheibani relative to Perle Totoson France Perle Totoson's profile →
Citations per field
00.5×3.1×
Perle Totoson · 1×
Citations per year

Countries citing papers authored by Mohammad Sheibani

Since Specialization
Citations

This map shows the geographic impact of Mohammad Sheibani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Sheibani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Sheibani more than expected).

Fields of papers citing papers by Mohammad Sheibani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Sheibani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Sheibani. The network helps show where Mohammad Sheibani may publish in the future.

Co-authors

The 25 scholars most cited alongside Mohammad Sheibani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mohammad Sheibani Line = papers co-authored together Mohammad Sheibani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
Hit paper breakdown →
2022152
2 202053
3 202347
4 202324
5 202223
6 201921
7 202021
8 202119
9 202319
10 202219
11 202019
12 202317
13 202316
14 201916
15 202115
16
Herbal Medicines and Other Traditional Remedies in Iran - A Tragedy Unfolds.
201814
17 202114
18 202314
19 202214
20 202313

About Mohammad Sheibani

Mohammad Sheibani is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine, Endocrine and Autonomic Systems and Physiology, having authored 58 papers that have together received 704 indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Asthma and respiratory diseases (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Electron Spin Resonance Studies (3 papers), Diabetes Treatment and Management (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Biological Psychiatry (33 citations), Endocrine and Autonomic Systems (51 citations), Cardiology and Cardiovascular Medicine (172 citations), Biophysics (25 citations) and Pharmacology (32 citations). Mohammad Sheibani has collaborated with scholars based in Iran, United States and Armenia. Frequent co-authors include Ahmad Reza Dehpour, Sadaf Nezamoleslami, Maryam Shayan, Yaser Azizi, Faezeh Eslami, Mohammad Hadi Farjoo, Hedyeh Faghir‐Ghanesefat, Hasan Yousefi‐Manesh, Mehdi Ghasemi and Azam Hosseinzadeh. Their work appears in journals such as Current Problems in Cardiology, Molecular Biology Reports, Pharmacological Reports, Tissue and Cell and Immunopharmacology and Immunotoxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact